Business Description
LeMaitre Vascular Inc
NAICS : 339112
SIC : 3841
ISIN : US5255582018
Description
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.37 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | 0.41 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 19.64 | |||||
| Beneish M-Score | -2.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.1 | |||||
| 3-Year EBITDA Growth Rate | 7.7 | |||||
| 3-Year EPS without NRI Growth Rate | 1.9 | |||||
| 3-Year FCF Growth Rate | 24.9 | |||||
| 3-Year Book Growth Rate | 18.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 8 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.18 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.41 | |||||
| 9-Day RSI | 49.28 | |||||
| 14-Day RSI | 47.41 | |||||
| 6-1 Month Momentum % | 8.61 | |||||
| 12-1 Month Momentum % | 11.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.75 | |||||
| Quick Ratio | 4.85 | |||||
| Cash Ratio | 3.49 | |||||
| Days Inventory | 263.21 | |||||
| Days Sales Outstanding | 47.57 | |||||
| Days Payable | 17.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.95 | |||||
| Dividend Payout Ratio | 0.47 | |||||
| 3-Year Dividend Growth Rate | 13.7 | |||||
| Forward Dividend Yield % | 0.97 | |||||
| 5-Year Yield-on-Cost % | 2.11 | |||||
| 3-Year Average Share Buyback Ratio | -3.1 | |||||
| Shareholder Yield % | 0.77 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.4 | |||||
| Operating Margin % | 17.46 | |||||
| Net Margin % | 14.24 | |||||
| ROE % | 9.37 | |||||
| ROA % | 8.12 | |||||
| ROIC % | 11.65 | |||||
| ROC (Joel Greenblatt) % | 35.3 | |||||
| ROCE % | 11.09 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 50.19 | |||||
| Forward PE Ratio | 36.53 | |||||
| PE Ratio without NRI | 50.19 | |||||
| Shiller PE Ratio | 60.52 | |||||
| Price-to-Owner-Earnings | 85.42 | |||||
| PEG Ratio | 6.35 | |||||
| PS Ratio | 7.14 | |||||
| PB Ratio | 4.45 | |||||
| Price-to-Tangible-Book | 7.3 | |||||
| Price-to-Free-Cash-Flow | 66.81 | |||||
| Price-to-Operating-Cash-Flow | 49.54 | |||||
| EV-to-EBIT | 37.99 | |||||
| EV-to-EBITDA | 29.39 | |||||
| EV-to-Revenue | 6.81 | |||||
| EV-to-Forward-Revenue | 5.69 | |||||
| EV-to-FCF | 63.68 | |||||
| Price-to-Projected-FCF | 2.51 | |||||
| Price-to-DCF (Earnings Based) | 1.62 | |||||
| Price-to-DCF (FCF Based) | 2.15 | |||||
| Price-to-Median-PS-Value | 1.26 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.7 | |||||
| Price-to-Graham-Number | 4.05 | |||||
| Price-to-Net-Current-Asset-Value | 9.63 | |||||
| Price-to-Net-Cash | 26.65 | |||||
| Earnings Yield (Greenblatt) % | 2.63 | |||||
| Forward Rate of Return (Yacktman) % | 10.72 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LMAT
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LeMaitre Vascular Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 177.172 | ||
| EPS (TTM) ($) | 1.13 | ||
| Beta | 0.5 | ||
| Volatility % | 28.78 | ||
| 14-Day RSI | 47.41 | ||
| 14-Day ATR ($) | 1.305011 | ||
| 20-Day SMA ($) | 57.0865 | ||
| 12-1 Month Momentum % | 11.88 | ||
| 52-Week Range ($) | 41.78 - 68.665 | ||
| Shares Outstanding (Mil) | 22.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LeMaitre Vascular Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LeMaitre Vascular Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
LeMaitre Vascular Inc Frequently Asked Questions
What is LeMaitre Vascular Inc(LMAT)'s stock price today?
The current price of LMAT is $57.03. The 52 week high of LMAT is $68.67 and 52 week low is $41.78.
When is next earnings date of LeMaitre Vascular Inc(LMAT)?
The next earnings date of LeMaitre Vascular Inc(LMAT) is 2023-10-27 Est..
Does LeMaitre Vascular Inc(LMAT) pay dividends? If so, how much?
The Dividend Yield %  of LeMaitre Vascular Inc(LMAT) is 0.95% (As of Today), Highest Dividend Payout Ratio of LeMaitre Vascular Inc(LMAT) was 0.61. The lowest was 0.25. And the median was 0.37. The  Forward Dividend Yield % of LeMaitre Vascular Inc(LMAT) is 0.97%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers